nutritionand,1502
inshort-termmechanicalcirculatorysupport,1206
Extracorporealsupport
extracorporealmembraneoxygenation,nutritionand,1502
postoperative,incardiopulmonarybypass,233–234,234f
Extrahepaticportosystemicshunt,471,472f
Extrastimulustesting,ablationand,359
Extremelylowbirthweight,definitionof,190b
Extremelyprematureneonate,initialresuscitationof,190–191
placentaltransfusionin,190–191
resuscitationgasin,191
temperaturein,190
ventilationin,191
F
Fabrydisease,cardiacinvolvementin,1094
Facioscapulohumeralmusculardystrophy,cardiacinvolvementin,1104
Failuretogrow,mechanismsof
growthfactorhormoneas,1496
hypermetabolismas,1495–1496
inadequatecaloricintakeas,1495
malabsorptionas,1496
Failuretoprogress,managementof,inFontanpathway,1295,1295b
Failuretothrive,atrioventricularseptaldefectsand,535
Familialscreening(general),1542–1543
foraortopathies,1543
forcardiomyopathy,1543
Family
ofchildrenwithcardiacdisease,1459–1463,1460f
communicationwith,1463
meetingneedsof,1462–1463
parentingand,1460–1461
psychologicalresponsesof,1461–1462
siblingsand,1462
whenchildisdying,1463
communicationto,1492,1493f
costofcongenitalheartdiseasein,187–188,188b
optimizingprenatalsupportof,163–170
practicalconsiderationsfor,167–168
initialcounselingsessionin,167–168
priortothefetalecho,167
recommendedcounselingstyleas,167
Familyhistory,cardiovascularriskfactorsand,423
Familyneeds,understanding,forinterstagemanagement,1309,1310f
Familysupport,managementof,inFontanpathway,1295–1296
Fast-trackcongenitalheartsurgery,1484
Fattyacidmetabolismdisorders,cardiacinvolvementin,1098
Feeding
forhemodynamicallysignificantarterialduct,198
managementof,inFontanpathway,1278,1291–1292
Femoralarteries,indiagnosticcatheterization,251
Femoralvein,indiagnosticcatheterization,243–244
Fenestrationclosure,inFontancirculation,1340–1342,1341f
Fetalaorticvalvuloplasty,patientselectionfor,150,151f
Fetalcardiacmagneticresonance,329–330,329f
Fetalcardiacsparing,95
Fetalcenters,ethicalissuesand,1468
Fetalcerebrovascularphysiology,incomplexcongenitalcardiacdisease,1394–
1396
Fetalcirculation,85–87
adaptationof,tohypoxia,117–118,119f
aorticisthmusin,87,87f
arterialductin,87
incongenitalheartdisease
assessmentof,111–123
patternsin,118–120,119t,120f
inhealthanddisease,90–96,90f
cardiacfunctionchanges,95–96
coronaryarterialflow,95,95f
diastolicmaturation,96
flowacrossaorticisthmus,93–94,93f–94f
flowinvenousduct,92,92f
flowofbloodtolungs,94–95,94f
flowtobrain,92–93
systolicmaturation,96
umbilicalcordflows,90–91,91f
hemodynamicassessmentin,114–116
ofnormallate-gestation,bymagneticresonanceimaging,116–117,117t,118f
ovalforamenin,87
physiologyof
magneticresonanceimagingtechniquesforassessing,112
normal,111–112
placentain,85–86,86f
venousductin,86–87,86f
Fetaldevelopment,cardiac,87–90
Fetalechocardiography
indicationsfor,125,126b,1535,1536t
modalitiesfor,126–131
colorDoppler,126–127
pulse-waveDoppleras,127–131
three-dimensional,126
two-dimensional,126,127f–128f
inpulmonarystenosis,785–786,785f
screeningwith,125,126t,1535,1536t
timingof,125–126
Fetalgrowthrestriction,oxygensaturationin,118
Fetalheart,83–107
abnormalitiesinpathologicpregnanciesand,98–100
autonomiccontrolof,83–84
biophysicalpropertiesof,84–85
circulationand,85–87